Skip to main content
. 2021 Jun 4;14(5):523–534. doi: 10.1007/s12195-021-00681-0

Figure 8.

Figure 8

“Internal” cysteine-to-serine mutations do not affect the cell death signaling activity of PEG cross-linked Gal1 C130. (a) Flow cytometry scatterplots of Jurkat T cells treated with 3.75 μM Gal1 C130 + PEGbisMal or 3.75 μM Gal1 C130 no IC + PEGbisMal. (b) Percentage of dead Jurkat T cells when treated with 0.5, 2.5 or 3.75 μM Gal1 C130 + PEGbisMal or Gal1 C130 no IC + PEGbisMal.